Cansortium Inc.

Recent News

  • Cansortium Announces Change of Auditor

    Miami, Florida--(Newsfile Corp. - February 11, 2020) - Cansortium Inc. (CSE: TIUM) ("Cansortium" or the "Company"), a vertically-integrated, global provider of premium-quality medical cannabis, announces that it has changed its auditor from Macias Gini & O'Connell LLP ("Former Auditor") to MNP LLP ("Successor Auditor") effective January 21, 2020. At the request of the Company, the Former Auditor resigned as the auditor of the Company effective January 21, 2020 and the board of directors of the Company appointed the Successor...

    2020-02-11 10:45 AM ET
  • Cansortium Announces a Reorganization of Senior Management and its Board of Directors, Significant Cost Reductions and the Prioritization and Acceleration of Growth in the U.S. Markets, Particularly Florida

    Miami, Florida--(Newsfile Corp. - October 22, 2019) - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company") and its Board of Directors (the "Board') have implemented a series of important corporate initiatives aimed at driving sustainable, profitable growth in the Company's core market of Florida by allocating the necessary capital to expand the number of dispensaries in the state to twenty by the end of 2019. These initiatives are also aimed at ensuring that the Company has the operational...

    2019-10-22 9:32 AM ET
  • Cansortium Inc. First Quarter Financial Results and Conference Call Scheduled for May 30

    Miami, Florida--(Newsfile Corp. - May 23, 2019) - Cansortium Inc. (CSE: TIUM) ("Cansortium" or the "Company"), a leading Florida-based medical cannabis company operating under the Fluent™ brand (formerly Knox Medical) and with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, will host a conference call on Thursday, May 30, 2019 at 5:00pm (ET) to review its first-quarter 2019 financial results, which will be released earlier that day.The conference call can be accessed...

    2019-05-23 2:51 PM ET
  • Cansortium Announces Private Placement of US$27,144,000 of Convertible Debentures

    Miami, Florida,--(Newsfile Corp. - May 23, 2019) - Cansortium Inc. (CSE: TIUM.U) ("Cansortium" or the "Company") is pleased to announce the closing today of its previously announced private placement financing conducted with Canaccord Genuity Corp. and Paradigm Capital Inc. (together with Canaccord Genuity Corp, the "Agents"). The Company issued on a private placement basis US$27,144,000 aggregate principal amount of convertible debenture units (the "Convertible Debenture Units" or the "Offered Securities") at an issue price of US$1,000 per Convertible...

    2019-05-23 2:01 PM ET
  • Cansortium Leadership to Present Tuesday, May 14 at Third Annual Canaccord Genuity Cannabis Conference in New York

    Miami, Florida--(Newsfile Corp. - May 7, 2019) - Cansortium Inc. (CSE: TIUM) ("Cansortium" or the "Company"), a leading Florida-based medical cannabis company operating under the Fluent™ Cannabis Care brand (formerly Knox Medical) and with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, announced that its Chief Executive Officer, Jose Hidalgo, will present Tuesday, May 14, 2019 at 3:40pm ET during the 3rd Annual Canaccord Genuity Cannabis Conference at the Grand Hyatt in...

    2019-05-07 4:38 PM ET
  • Cansortium Inc. Expanding and Rebranding its Medical Cannabis Dispensary Network: Knox Medical is Becoming Fluent(TM) Cannabis Care

    Miami, Florida--(Newsfile Corp. - May 6, 2019) - Cansortium Inc. (CSE: TIUM) ("Cansortium" or the "Company"), a leading Florida-based medical cannabis company with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, announced the launch of Fluent™ Cannabis Care. Fluent replaces the Knox Medical brand, under which the Company currently operates cultivation, processing and dispensary facilities in Florida, Texas, Pennsylvania, and Puerto Rico, with plans to expand into international markets."Launching the Fluent Cannabis...

    2019-05-06 9:10 AM ET
  • Cansortium Awarded Cannabis Cultivation, Processing and Medical Sales License by Health Canada

    Miami, Florida--(Newsfile Corp. - May 6, 2019) - Cansortium Inc. (CSE: TIUM) (the "Company" or "Cansortium"), a leading Florida-based multi-state operator ("MSO") medical cannabis company with a mission to deliver the highest standards of cannabis care from nursery to lab to shelf, announced that Health Canada, pursuant to the Cannabis Act, has granted to Cansortium Canada, an indirect wholly-owned subsidiary of the Company, a cannabis cultivation, processing and medical sales license.Cansortium Founder & CEO Jose Hidalgo commented, "After more than...

    2019-05-06 9:06 AM ET
  • Cansortium Inc. Announces Key Appointments to Senior Leadership Team

    Miami, Florida--(Newsfile Corp. - April 26, 2019) - Cansortium Inc. (CSE: TIUM.U) ("Cansortium" or the "Company"), a vertically-integrated, multi-state provider of high-quality medical cannabis, announced today the appointment of two new members to its expanding leadership team. Dr. Jennifer McCafferty-Fernandez - Chief Science OfficerDr. Jennifer McCafferty-Fernandez has joined the Company as Chief Science Officer, reporting to Jose Hidalgo, Chief Executive Officer.Dr. McCafferty-Fernandez earned her PhD from the University of Miami in the Department of Molecular and Cellular Pharmacology...

    2019-04-26 11:56 AM ET